- NCIt
- C37869
Loading cancer entity…
Loading cancer entity…
Research activity
Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.
| Window | Period | Records (count) | Exact query | Computed | Source |
|---|---|---|---|---|---|
| All time | … → 2026-09-30 | 147 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) | 2026-09-30 | pubmed |
| Last 5 years | 2021-01-01 → 2026-12-31 | 61 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2021/01/01:2026/12/31[dp]) | 2026-09-30 | pubmed |
| Preceding 5-year window | 2020-09-30 → 2025-09-29 | 53 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2020/09/30:2025/09/29[dp]) | 2026-09-30 | pubmed |
| Last 12 months | 2025-09-30 → 2026-09-30 | 12 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2025/09/30:2026/09/30[dp]) | 2026-09-30 | pubmed |
| y2016 | 2016-01-01 → 2016-12-31 | 14 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2016/01/01:2016/12/31[dp]) | 2026-09-30 | pubmed |
| y2017 | 2017-01-01 → 2017-12-31 | 11 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2017/01/01:2017/12/31[dp]) | 2026-09-30 | pubmed |
| y2018 | 2018-01-01 → 2018-12-31 | 6 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2018/01/01:2018/12/31[dp]) | 2026-09-30 | pubmed |
| y2019 | 2019-01-01 → 2019-12-31 | 14 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2019/01/01:2019/12/31[dp]) | 2026-09-30 | pubmed |
| y2020 | 2020-01-01 → 2020-12-31 | 15 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2020/01/01:2020/12/31[dp]) | 2026-09-30 | pubmed |
| y2021 | 2021-01-01 → 2021-12-31 | 12 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2021/01/01:2021/12/31[dp]) | 2026-09-30 | pubmed |
| y2022 | 2022-01-01 → 2022-12-31 | 5 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2022/01/01:2022/12/31[dp]) | 2026-09-30 | pubmed |
| y2023 | 2023-01-01 → 2023-12-31 | 23 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2023/01/01:2023/12/31[dp]) | 2026-09-30 | pubmed |
| y2024 | 2024-01-01 → 2024-12-31 | 11 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2024/01/01:2024/12/31[dp]) | 2026-09-30 | pubmed |
| y2025 | 2025-01-01 → 2025-12-31 | 10 | ("Gray-Zone Lymphoma"[tiab] OR "Hodgkin-Like Anaplastic Large Cell Lymphoma"[tiab] OR "Large B-Cell Lymphoma with Hodgkin Features"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"[tiab] OR "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma"[tiab]) AND (2025/01/01:2025/12/31[dp]) | 2026-09-30 | pubmed |
Data updated 4 hours agoSource updated unknownsource: pubmed E-utilities
Literature
Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.
Data not yet available